FDA allows standalone use of nasal spray antidepressant Spravato (esketamine) : Shots - Health News
NPR   15 days ago
ads
Read Full Story
FDA allows standalone use of nasal spray antidepressant Spravato (esketamine) : Shots - Health News  NPRFDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment  CNBCSPRAVATO® (esketamine) approved in the U.S. as the...